Picture of Rapt Therapeutics logo

RAPT — Rapt Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapMomentum Trap

Brief: Rapt Therapeutics Q3 Net Income USD -18.432 Million

Nov 12 (Reuters) - Rapt Therapeutics Q3 operating income USD -19.788 million.
* Q3 operating expenses USD 19.788 million
* Q3 basic EPS USD -0.47

Recent news on Rapt Therapeutics

See all news